Hochschulschrift
Entry and competition in the pharmaceutical market following patent expiry : evidence from macro and micro data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Univ., Diss., 2011
- Schlagwort
-
Generika
Pharmazeutisches Produkt
Markteintritt
Wettbewerb
Deutschland
Generikum
Impfstoff
Arzneimittel
Heilmittel
Markteintrittsstrategie
Marktzugang
Wettbewerb
Wettbewerbsfreiheit
Wettbewerbsfähigkeit
Deutschland
- Urheber
- URN
-
urn:nbn:de:bvb:19-131082
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Information and competition entry
Information and Competition Entry
Does increased price competition reduce entry of new pharmaceutical products?
Exchange Competition, Entry, and Welfare
Market Entry Regulation and International Competition
Reputation, Competition, and Entry in Procurement
Free entry, regulatory competition, and globalization
Entry barriers, competition, and technology adoption
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Oligopolistic Competition, Product Variety and Entry Deterrence
Information and competition entry
Information and Competition Entry
Does increased price competition reduce entry of new pharmaceutical products?
Exchange Competition, Entry, and Welfare
Market Entry Regulation and International Competition
Reputation, Competition, and Entry in Procurement
Free entry, regulatory competition, and globalization
Entry barriers, competition, and technology adoption
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Oligopolistic Competition, Product Variety and Entry Deterrence
Information and competition entry
Information and Competition Entry
Does increased price competition reduce entry of new pharmaceutical products?
Exchange Competition, Entry, and Welfare
Market Entry Regulation and International Competition
Reputation, Competition, and Entry in Procurement
Free entry, regulatory competition, and globalization
Entry barriers, competition, and technology adoption
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?